Literature DB >> 9313122

Toxic epidermal necrolysis.

J T Murphy1, G F Purdue, J L Hunt.   

Abstract

Toxic epidermal necrolysis (TEN) is a poorly understood and devastating condition. It is usually diagnosed in a primary care setting. Treatment of severe cases by burn care personnel is usually by referral. In this review, we report excessive mortality rates associated with prolonged use of systemic steroid therapy and delayed referral (more than 1 week from diagnosis). Forty-four consecutive patients admitted to a regional burn center with the diagnosis of TEN over a 14-year period, (0.7% of all admissions) were included. Precipitating factors were identified in 30 cases. Twenty-one patients had known prehospital allergy conditions directly related to the inciting agent. The mean age of this population was 44.9 years, and the mean total body surface area (TBSA) injury was 52.4%. Eighty-four and one-half percent of all patients with TEN were admitted to the ICU. Twenty-four patients required ventilator support. Overall mortality rate was 36%. Nonsurviving patients had a mean age of 61.6 years, compared to 35.3 years for survivors. Nonsurvivors had a mean TBSA of 64.4%, survivors had a mean TBSA of 44%. TEN, although a nonthermal injury, is best managed by personnel experienced in the care of severe thermal injuries. Despite the availability of this expertise, delayed transfer of severe presentations continues to contribute to exceptionally high morbidity and mortality rates.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9313122

Source DB:  PubMed          Journal:  J Burn Care Rehabil        ISSN: 0273-8481


  6 in total

1.  Use of Xe-Derma(®), a novel biological cover, in a female patient with toxic epidermal necrolysis.

Authors:  B Lipový; H Rihová; Y Kaloudová; R Mager; I Suchánek
Journal:  Ann Burns Fire Disasters       Date:  2014-09-30

Review 2.  SJS/TEN 2017: Building Multidisciplinary Networks to Drive Science and Translation.

Authors:  Katie D White; Riichiro Abe; Michael Ardern-Jones; Thomas Beachkofsky; Charles Bouchard; Bruce Carleton; James Chodosh; Ricardo Cibotti; Robert Davis; Joshua C Denny; Roni P Dodiuk-Gad; Elizabeth N Ergen; Jennifer L Goldman; James H Holmes; Shuen-Iu Hung; Mario E Lacouture; Rannakoe J Lehloenya; Simon Mallal; Teri A Manolio; Robert G Micheletti; Caroline M Mitchell; Maja Mockenhaupt; David A Ostrov; Rebecca Pavlos; Munir Pirmohamed; Elena Pope; Alec Redwood; Misha Rosenbach; Michael D Rosenblum; Jean-Claude Roujeau; Arturo P Saavedra; Hajirah N Saeed; Jeffery P Struewing; Hirohiko Sueki; Chonlaphat Sukasem; Cynthia Sung; Jason A Trubiano; Jessica Weintraub; Lisa M Wheatley; Kristina B Williams; Brandon Worley; Wen-Hung Chung; Neil H Shear; Elizabeth J Phillips
Journal:  J Allergy Clin Immunol Pract       Date:  2018 Jan - Feb

3.  Stevens-Johnson Syndrome and toxic epidermal necrolysis: a multi-aspect comparative 7-year study from the People's Republic of China.

Authors:  Jie Sun; Jin Liu; Qing-Li Gong; Gao-Zhong Ding; Li-Wen Ma; Li-Chao Zhang; Yan Lu
Journal:  Drug Des Devel Ther       Date:  2014-12-12       Impact factor: 4.162

4.  USA: Ophthalmologic Evaluation and Management of Acute Stevens-Johnson Syndrome.

Authors:  Darren G Gregory
Journal:  Front Med (Lausanne)       Date:  2021-07-07

5.  Management of burn injuries--recent developments in resuscitation, infection control and outcomes research.

Authors:  David J Dries
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2009-03-11       Impact factor: 2.953

6.  Incidence, causative drugs, and economic consequences of drug-induced SJS, TEN, and SJS-TEN overlap and potential drug-drug interactions during treatment: a retrospective analysis at an Indonesian referral hospital.

Authors:  Rizky Abdulah; Tazkia F Suwandiman; Nadhira Handayani; Dika P Destiani; Auliya A Suwantika; Melisa I Barliana; Keri Lestari
Journal:  Ther Clin Risk Manag       Date:  2017-07-21       Impact factor: 2.423

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.